BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21909379)

  • 1. HIV incidence and risk factors for acquisition in HIV discordant couples in Masaka, Uganda: an HIV vaccine preparedness study.
    Ruzagira E; Wandiembe S; Abaasa A; Bwanika AN; Bahemuka U; Amornkul P; Price MA; Grosskurth H; Kamali A
    PLoS One; 2011; 6(8):e24037. PubMed ID: 21909379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of establishing an HIV vaccine preparedness cohort in a population of the Uganda Police Force: Lessons learnt from a prospective study.
    Bahemuka UM; Abaasa A; Seeley J; Byaruhanga M; Kamali A; Mayaud P; Kuteesa M
    PLoS One; 2020; 15(4):e0231640. PubMed ID: 32302334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and incidence of HIV in a rural community-based HIV vaccine preparedness cohort in Masaka, Uganda.
    Ruzagira E; Wandiembe S; Abaasa A; Levin J; Bwanika A; Bahemuka U; Price MA; Kamali A
    PLoS One; 2011; 6(6):e20684. PubMed ID: 21677779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retention of adults from fishing communities in an HIV vaccine preparedness study in Masaka, Uganda.
    Bahemuka UM; Abaasa A; Ruzagira E; Lindan C; Price MA; Kamali A; Fast P
    PLoS One; 2019; 14(1):e0198460. PubMed ID: 30640918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Loss to Follow-Up in an HIV Vaccine Preparedness Study in Masaka, Uganda.
    Kabarambi A; Kansiime S; Kusemererwa S; Kitonsa J; Kaleebu P; Ruzagira E;
    Int J Environ Res Public Health; 2022 May; 19(11):. PubMed ID: 35681962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary HIV prevention in pregnant and lactating Ugandan women: A randomized trial.
    Homsy J; King R; Bannink F; Namukwaya Z; Vittinghof E; Amone A; Ojok F; Rukundo G; Amama S; Etima J; Matovu J; Weissglas F; Ojom L; Atim P; Darbes L; Byamugisha J; Rutherford G; Katabira E; Fowler MG;
    PLoS One; 2019; 14(2):e0212119. PubMed ID: 30802277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The social dynamics of HIV transmission as reflected through discordant couples in rural Uganda.
    Serwadda D; Gray RH; Wawer MJ; Stallings RY; Sewankambo NK; Konde-Lule JK; Lainjo B; Kelly R
    AIDS; 1995 Jul; 9(7):745-50. PubMed ID: 7546420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterosexual transmission of HIV in Haiti.
    Deschamps MM; Pape JW; Hafner A; Johnson WD
    Ann Intern Med; 1996 Aug; 125(4):324-30. PubMed ID: 8678397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia.
    Hira SK; Feldblum PJ; Kamanga J; Mukelabai G; Weir SS; Thomas JC
    Int J STD AIDS; 1997 Apr; 8(4):243-50. PubMed ID: 9147157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa.
    Allen S; Tice J; Van de Perre P; Serufilira A; Hudes E; Nsengumuremyi F; Bogaerts J; Lindan C; Hulley S
    BMJ; 1992 Jun; 304(6842):1605-9. PubMed ID: 1628088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal contraception does not increase women's HIV acquisition risk in Zambian discordant couples, 1994-2012.
    Wall KM; Kilembe W; Vwalika B; Htee Khu N; Brill I; Chomba E; Johnson BA; Haddad L; Tichacek A; Allen S
    Contraception; 2015 Jun; 91(6):480-7. PubMed ID: 25708502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV incidence and factors associated with seroconversion in a rural community home based counseling and testing program in Eastern Uganda.
    Okiria AG; Okui O; Dutki M; Baryamutuma R; Nuwagaba CK; Kansiime E; Ojamuge G; Mugweri J; Fleuret J; King R; Bazeyo W; Lindan C
    AIDS Behav; 2014 Jan; 18 Suppl 1():S60-8. PubMed ID: 23695518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 transmission within marriage in rural Uganda: a longitudinal study.
    Biraro S; Ruzagira E; Kamali A; Whitworth J; Grosskurth H; Weiss HA
    PLoS One; 2013; 8(2):e55060. PubMed ID: 23390512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy.
    Reynolds SJ; Makumbi F; Nakigozi G; Kagaayi J; Gray RH; Wawer M; Quinn TC; Serwadda D
    AIDS; 2011 Feb; 25(4):473-7. PubMed ID: 21160416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of oral pre-exposure prophylaxis (PrEP) uptake among individuals in a HIV vaccine preparedness cohort in Masaka, Uganda.
    Kusemererwa S; Kansiime S; Mutonyi G; Namirembe A; Katana S; Kitonsa J; Kakande A; Okello JM; Kaleebu P; Ruzagira E
    Medicine (Baltimore); 2021 Nov; 100(44):e27719. PubMed ID: 34871265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for HIV transmission among heterosexual discordant couples in South India.
    Kumarasamy N; Venkatesh KK; Srikrishnan AK; Prasad L; Balakrishnan P; Thamburaj E; Sharma J; Solomon S; Mayer K
    HIV Med; 2010 Mar; 11(3):178-86. PubMed ID: 19780862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cango Lyec (Healing the Elephant): HIV Prevalence and Vulnerabilities Among Adolescent Girls and Young Women in Postconflict Northern Uganda.
    Muyinda H; Jongbloed K; Zamar DS; Malamba SS; Ogwang MD; Katamba A; Oneka A; Atim S; Odongpiny TO; Sewankambo NK; Schechter MT; Spittal PM
    J Acquir Immune Defic Syndr; 2023 Oct; 94(2):95-106. PubMed ID: 37276188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of fishing communities around Lake Victoria, Uganda, as potential populations for future HIV vaccine efficacy studies: an observational cohort study.
    Kiwanuka N; Mpendo J; Nalutaaya A; Wambuzi M; Nanvubya A; Kitandwe PK; Muyanja E; Ssempiira J; Balyegisawa A; Ssetaala A;
    BMC Public Health; 2014 Sep; 14():986. PubMed ID: 25242015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya.
    Nyabuti MN; Petersen ML; Bukusi EA; Kamya MR; Mwangwa F; Kabami J; Sang N; Charlebois ED; Balzer LB; Schwab JD; Camlin CS; Black D; Clark TD; Chamie G; Havlir DV; Ayieko J
    PLoS One; 2021; 16(2):e0243167. PubMed ID: 33544717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.